1-[(benzyloxy)carbonyl]-3-hydroxypyrrolidine-2-carboxylic acid, 500mg

N-(4-Bromo-2-chloro-6-methylphenyl)acetamide, 98%, 250mg

2-Cyano-4-methylpyridine 1-oxide, 1g

7-Methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98+%, 1g

4-methylenepiperidine hydrobromide, 250mg

tert-Butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate, 95.0%, 500mg

(3aR,8aS)-2-(Pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole, 97%, 100mg

Propanoic acid, 3,3'-[1,2-ethanediylbis(oxy)]bis-, 98%, 1g

Methyl 5-bromo-4-chloronicotinate, 95.0%, 5g

METHYL 2-BROMO-5-FORMYLBENZOATE, 95.0%, 10g

Plan phase S100x/1.25 objectif corrigé à l'infini à immersion dans l'huile

1-methyl-6-nitro-2,3-dihydro-1H-indol-2-one, 95.0%, 100mg

2-(Cyclohexylthio)benzenamine, 95%, 250mg